// App-Quantinova.ai

AB0583 : EFFECTIVENESS AND SAFETY OF SHORT-TERM TREATMENT OF ACTIVE RHEUMATOID ARTHRITIS (RA) MODERATE TO SEVERE WITH TOCILIZUMAB

Researchers

Presenter

  • V. Rodriguez-Garcia

Principal Investigators

  • M. Ordonez

  • S. Manrique-Arija

  • M. Irigoyen

  • A. Fernandez-Nebro

  • C. Romero-Barco

  • L. Nieves-Martin

  • I. Urena

  • F. Jimenez-Nunez

  • B. Panero

  • M. Belmonte-Lopez

  • L. Cano-Garcia

  • V. Coret

Medical Centers

  • Pediatric Department, Hospital Carlos Haya, Malaga, Spain

Locations

  • Spain

Companies

  • N/A

Study Components

Therapeutic Area

  • Autoimmune (AI)

Disease

  • Rheumatoid arthritis

  • Neutropenia

  • Bacterial Skin Infection

  • Inflammatory Arthritis

Biomarkers

  • N/A

Drug/Treatment

  • Hydroxychloroquine

  • Tocilizumab

Outcome

  • N/A

Study Design

  • N/A

Phase

  • NA

Study Id's

  • N/A

Sponsors

  • N/A

Result

  • Interim

Copyright © 2026. QuantiNova All rights reserved